These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29208932)

  • 21. Rabbit genital tissue is susceptible to infection by rabbit oral papillomavirus: an animal model for a genital tissue-targeting papillomavirus.
    Harvey SB; Cladel NM; Budgeon LR; Welsh PA; Griffith JW; Lang CM; Christensen ND
    J Virol; 1998 Jun; 72(6):5239-44. PubMed ID: 9573297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of canine oral papillomavirus in generalized oral and cutaneous verrucosis in a Chinese Shar Pei dog.
    Sundberg JP; Smith EK; Herron AJ; Jenson AB; Burk RD; Van Ranst M
    Vet Pathol; 1994 Mar; 31(2):183-7. PubMed ID: 8203080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mouse papillomavirus MmuPV1 infects oral mucosa and preferentially targets the base of the tongue.
    Cladel NM; Budgeon LR; Balogh KK; Cooper TK; Hu J; Christensen ND
    Virology; 2016 Jan; 488():73-80. PubMed ID: 26609937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High viral load of human wart-associated papillomaviruses (PV) but not beta-PV in cutaneous warts independent of immunosuppression.
    Köhler A; Meyer T; Stockfleth E; Nindl I
    Br J Dermatol; 2009 Sep; 161(3):528-35. PubMed ID: 19519829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models.
    Gunder LC; Blaine-Sauer S; Johnson HR; Shin MK; Auyeung AS; Zhang W; Leverson GE; Ward-Shaw ET; King RE; McGregor SM; Matkowskyj KA; Lambert PF; Carchman EH
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strain-specific properties and T cells regulate the susceptibility to papilloma induction by Mus musculus papillomavirus 1.
    Handisurya A; Day PM; Thompson CD; Bonelli M; Lowy DR; Schiller JT
    PLoS Pathog; 2014 Aug; 10(8):e1004314. PubMed ID: 25121947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice.
    Revaz V; Benyacoub J; Kast WM; Schiller JT; De Grandi P; Nardelli-Haefliger D
    Virology; 2001 Jan; 279(1):354-60. PubMed ID: 11145916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral wart associated with human papillomavirus type 2.
    Terai M; Takagi M; Matsukura T; Sata T
    J Oral Pathol Med; 1999 Mar; 28(3):137-40. PubMed ID: 10069543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
    Carter JJ; Madeleine MM; Shera K; Schwartz SM; Cushing-Haugen KL; Wipf GC; Porter P; Daling JR; McDougall JK; Galloway DA
    Cancer Res; 2001 Mar; 61(5):1934-40. PubMed ID: 11280749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosally-derived HPV-40 can infect both human genital foreskin and cutaneous hand skin tissues grafted into athymic mice.
    Jenkins AL; Lang CM; Budgeon LR; Cladel NM; Reed CA; Welch DR; Christensen ND
    Virus Res; 2003 May; 93(1):109-14. PubMed ID: 12727348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV and cancer of the oral cavity.
    Hübbers CU; Akgül B
    Virulence; 2015; 6(3):244-8. PubMed ID: 25654476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermodysplasia verruciformis-associated and genital-mucosal high-risk human papillomavirus DNA are prevalent in nevus sebaceus of Jadassohn.
    Carlson JA; Cribier B; Nuovo G; Rohwedder A
    J Am Acad Dermatol; 2008 Aug; 59(2):279-94. PubMed ID: 18638629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection.
    Nicholls PK; Klaunberg BA; Moore RA; Santos EB; Parry NR; Gough GW; Stanley MA
    Virology; 1999 Dec; 265(2):365-74. PubMed ID: 10600607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
    Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
    mBio; 2016 May; 7(3):. PubMed ID: 27143385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus infections in children: the potential role of maternal transmission.
    Syrjänen S; Puranen M
    Crit Rev Oral Biol Med; 2000; 11(2):259-74. PubMed ID: 12002819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: lack of correlation with human papillomavirus status.
    Cairey-Remonnay S; Humbey O; Mougin C; Algros MP; Mauny F; Kanitakis J; Euvrard S; Laurent R; Aubin F
    J Invest Dermatol; 2002 Jun; 118(6):1026-31. PubMed ID: 12060398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomaviruses of the mucosal type are present in some cases of extragenital Bowen's disease.
    Zheng S; Adachi A; Shimizu M; Shibata SI; Yasue S; Sakakibara A; Sugiura M; Nagasaka T; Tomita Y
    Br J Dermatol; 2005 Jun; 152(6):1243-7. PubMed ID: 15948988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
    Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
    J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mus musculus papillomavirus 1 is a key driver of skin cancer development upon immunosuppression.
    Dorfer S; Strasser K; Schröckenfuchs G; Bonelli M; Bauer W; Kittler H; Cataisson C; Fischer MB; Lichtenberger BM; Handisurya A
    Am J Transplant; 2021 Feb; 21(2):525-539. PubMed ID: 33063442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.